Jain Global’s Terns Pharmaceuticals TERN Stock Holding History

Jain Global’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-37,366	Closed	-$1.97M	–	2043
2026 Q1	$1.97M	Sell	37,366 -57,758	-61%	-$2.37M	0.01%	690
2025 Q4	$3.84M	Buy	+95,124	New	+$2.2M	0.02%	468

Other funds holding TERN

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Jain Global's TERN Position: Q2 2026 in Review

Jain Global sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 37,366 shares — an estimated $1.97M sold.

Jain Global first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $3.84M in Q4 2025. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Jain Global reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Jain Global sold 37,366 Terns Pharmaceuticals shares in Q2 2026, an estimated $1.97M.
Jain Global first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Jain Global's Terns Pharmaceuticals position peaked at $3.84M in Q4 2025.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.